N/A
16,739 FDA adverse event reports analyzed
Last updated: 2026-04-15
PYRIDOSTIGMINE BROMIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS). The most commonly reported adverse reactions for PYRIDOSTIGMINE BROMIDE include MYASTHENIA GRAVIS, FATIGUE, DRUG INEFFECTIVE, ASTHENIA, OFF LABEL USE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PYRIDOSTIGMINE BROMIDE.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 16,739 FDA FAERS reports that mention PYRIDOSTIGMINE BROMIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include MYASTHENIA GRAVIS, FATIGUE, DRUG INEFFECTIVE, ASTHENIA, OFF LABEL USE, DIARRHOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.